Fit-for-purpose validation and inter-laboratory cross-validation of a TBNK flow cytometry assay with improved B cell monitoring capabilities

Home > Science Hub > Fit-for-purpose validation and inter-laboratory cross-validation of a TBNK flow cytometry assay with improved B cell monitoring capabilities
Back to the list

April 14, 2026

You might also be interested by

Videos

Chats with our Scientific Advisory Board: Rupert Vessey, PhD with Christopher Ung on Drug Development

July 21, 2026

More info

Videos

Chats with our Scientific Advisory Board: Carl June, MD with Christopher Ung on Immunotherapies

July 21, 2026

More info

Videos

Chats with our Scientific Advisory Board: George Demetri, MD and Charles Sawyers, MD with Christopher Ung on Immunotherapies

July 21, 2026

More info

Press Releases

CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development

July 15, 2026

More info